From July 1, 2023 to September 30, 2023, the company has repurchased 0 shares, representing 0% for $0 million. With this, the company has completed the repurchase of 517,399 shares, representing 3.5% for $0.63 million under the buyback announced on November 10, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1116 USD | +0.36% | +0.36% | -43.64% |
20/05 | Onconetix, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
11/04 | Onconetix, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
-43.64% | 2.98M | |
-2.99% | 89.49B | |
+2.50% | 40.67B | |
-12.01% | 33.15B | |
+62.80% | 26.45B | |
-19.79% | 14.69B | |
-8.58% | 12.89B | |
-12.34% | 11.54B | |
-43.92% | 11.34B | |
+3.82% | 8.84B |
- Stock Market
- Equities
- ONCO Stock
- News Onconetix, Inc.
- Tranche Update on Blue Water Biotech, Inc.'s Equity Buyback Plan announced on November 10, 2022.